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Purpose: Recent findings indicate that the beneficial effects of adipose stem cells (ASCs), 
reported in several neurodegenerative experimental models, could be due to their paracrine 
activity mediated by the release of exosomes. The aim of this study was the development 
and validation of an innovative exosome-labeling protocol that allows to visualize them with 
magnetic resonance imaging (MRI).
Materials and methods: At first, ASCs were labeled using ultrasmall superparamagnetic 
iron oxide nanoparticles (USPIO, 4–6 nm), and optimal parameters to label ASCs in terms of 
cell viability, labeling efficiency, iron content, and magnetic resonance (MR) image contrast 
were investigated. Exosomes were then isolated from labeled ASCs using a standard isolation 
protocol. The efficiency of exosome labeling was assessed by acquiring MR images in vitro and 
in vivo as well as by determining their iron content. Transmission electron microscopy images 
and histological analysis were performed to validate the results obtained.
Results: By using optimized experimental parameters for ASC labeling (200 µg Fe/mL of 
USPIO and 72 hours of incubation), it was possible to label 100% of the cells, while their viabil-
ity remained comparable to unlabeled cells; the detection limit of MR images was of 102 and 
2.5×103 ASCs in vitro and in vivo, respectively. Exosomes isolated from previously labeled 
ASCs retain nanoparticles, as demonstrated by transmission electron microscopy images. The 
detection limit by MRI was 3 µg and 5 µg of exosomes in vitro and in vivo, respectively.
Conclusion: We report a new approach for labeling of exosomes by USPIO that allows detec-
tion by MRI while preserving their morphology and physiological characteristics.
Keywords: MRI, superparamagnetic iron oxide nanoparticles, cellular imaging, stem cells 
labeling, exosome labeling
Introduction
Mesenchymal stem cells are adult multipotent stem cells capable of self-renewal and 
differentiation. Among the different mesenchymal stem cells that can be isolated, 
adipose stem cells (ASCs) are of great interest for potential therapeutic applications 
due to easy availability, to their ability to migrate to damaged tissue, to their capability 
to differentiate, and contribution in reparative processes.1–3 Moreover, it has been 
recently demonstrated that in vivo administration of ASCs ameliorates the disease 
condition in several neurodegenerative animal models.4–6 In particular, it has been 
reported that transplantation of autologous ASCs has a therapeutic effect in experi-
mental autoimmune encephalomyelitis and in murine model of familial amyotrophic 
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lateral sclerosis.5,6 Literature findings indicate that ASCs 
exert their action through paracrine activity rather than 
through engraftment.7–9 Furthermore, this paracrine activity 
is mediated by the release of membrane vesicles, such as 
exosomes.10 These vesicles are from 30 nm to 100 nm in size 
and are of endosomal origin;11 for this reason, they contain 
typical endosome-associated proteins, such as tetraspanin, 
alix, and heat-shock proteins, some of which are used as 
specific and quantitative endosomal markers.12 Exosomes 
contain lipids, proteins, and nucleic acid (in particular, 
mRNA, tRNA, miRNA, and noncoding RNA) that can be 
transferred to cells and regulate their activities.12,13 Based on 
the accumulating evidence for the key role of exosomes in 
neuronal protection, nerve regeneration, remyelination, and 
synaptic plasticity,14–17 several authors support the idea that 
exosomes can recapitulate the neuroprotective effect of stem 
cells and suggest their use for a noncell-based therapy of 
neurodegenerative diseases.3,15–17 Nevertheless, elucidation of 
the action mechanism of both ASCs and exosomes requires 
knowledge of their homing in the recipient body.
In order to understand where stem cells or exosomes 
exert their therapeutic effect, the ability to track cells and 
exosomes in a noninvasive manner, with an appropriate 
imaging method, such as magnetic resonance imaging 
(MRI), becomes crucial. Recently, nanotechnologies have 
contributed to advances in in vivo high-resolution imaging 
to monitor stem cells and exosomes tracking and homing, 
providing useful insights in their mechanism of action.18–23 
To produce a detectable change in signal intensity, cells or 
exosomes must be labeled with magnetic resonance (MR) 
contrast agents. In this regard, superparamagnetic iron oxide 
nanoparticles, which are small crystalline magnetite struc-
tures ranging in size from 5 nm to 150 nm, have been widely 
used to magnetically label stem cells and exosomes.23,24
To the best of our knowledge, a single method to label 
exosomes for MRI has been reported: exosomes are loaded 
with nanoparticles through electroporation.23,25 Electropo-
ration is an old method that has been used for many years. 
It uses a long electric pulse to temporarily disturb the phos-
pholipid bilayer, creating temporary pores in membranes, 
allowing molecules, such as nanoparticles, to pass into the 
exosomes. A temporary breakage of the membrane may alter 
their protein composition that might affect the function of 
the exosomes. Therefore, it is essential to find an alternative 
method that preserves membrane integrity.
Here, we set up an innovative approach for exosome 
labeling that preserves their morphology and physiological 
characteristics. Specifically, we show that by labeling ASCs 
with ultrasmall superparamagnetic iron oxide nanoparticles 
(USPIO, 4–6 nm) before vesicles extraction, the isolated 
exosomes retain nanoparticles and can be visualized by MRI. 
This study aims at validating this new USPIO-based exosome 
labeling method by monitoring the efficiency of the labeling 
with MRI both in ASCs and in extracted exosomes. We also 
demonstrate the value of the MRI-based approach, which 
allowed us to measure small amounts of USPIO-labeled cells 
or exosomes in in vitro and in vivo conditions.
Materials and methods
cell culture
Murine ASCs were isolated from inguinal adipose tissues of 
male C57BL/6 mice (Charles River Laboratories, Wilmington, 
MA, USA), as previously described.2 Briefly, the lipoaspirate 
was incubated in Hank’s Balanced Salt Solution (Thermo 
Fisher Scientific, Waltham, MA, USA) with collagenase type 
I (Thermo Fisher Scientific) and bovine serum albumin (Pan-
Reac AppliChem, Darmstadt, Germany). After incubation, a 
stromal vascular fraction was obtained by ultracentrifugation, 
resuspended in NH
4
Cl, centrifuged, and filtered to remove cell 
debris. Cells were cultured using Dulbecco’s Modified Eagle’s 
Medium with 10% fetal bovine serum (FBS), 100 U/mL 
penicillin, and 100 µg/mL streptomycin (all from Thermo 
Fisher Scientific) and incubated at 37°C/5% CO
2
.
Iron oxide nanoparticles labeling of ascs
Commercial USPIO (magnetite Fe
3
O
4
; Sigma-Aldrich 
Co., St Louis, MO, USA; catalog #725331, particle size 
4–6 nm, stock solution 5 mg Fe/mL) were used to label 
ASCs (ASC-USPIO). The experiment was designed with two 
approaches. In the first approach, 105 cells were incubated 
with increasing concentrations of nanoparticles (equivalent 
to 0, 12.5, 25, 50, 100, 200 µg Fe/mL) at different time points 
(24 hours and 72 hours). USPIO were diluted in culture 
medium (Dulbecco’s Modified Eagle’s Medium with 10% 
FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin). 
After incubation, cells were washed twice with phosphate-
buffered saline (PBS), trypsinized, and counted, and 105 cells 
were resuspended in a gel matrix. In the second approach, 
200 µg Fe/mL of USPIO were used to label a variable cell 
concentration (from 102 cells to 105 cells) for 72 hours. After 
incubation, cells were washed twice with PBS, trypsinized, 
counted, and resuspended at the appropriate cell number 
(from 102 cells to 105 cells).
Cytotoxicity of nanoparticles was determined by Trypan 
blue (TB) exclusion assay: cells were washed twice with 
PBS, trypsinized, and incubated with TB dye solution. The 
TB dye stains dead cells in blue color, while the live cells 
remain unstained. Cell viability was analyzed with univariate 
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analysis of variance; P,0.05 was considered as statistically 
significant.
Efficiency of ASC labeling
To verify the internalization of nanoparticles by ASCs, cells 
were stained with Prussian blue (PB; Perls’ acid ferrocyanide) 
method and counterstained with nuclear fast red. Cells were 
fixed with a 2% solution of glutaraldehyde/paraformaldehyde 
for 30 minutes at room temperature and washed twice with 
PBS. The cells were incubated for 40 minutes in a solution 
of 1% HCl and 2% potassium ferrocyanide, washed twice 
with distilled water, and counterstained using nuclear fast 
red for 15 minutes. Cells were then washed twice with 
distilled water and finally embedded in a mounting medium 
(Dako Mounting Medium; Agilent Technologies, Santa 
Clara, CA, USA). The nanoparticles internalization was 
investigated using a light microscope (Olympus BXS1): 
iron nanoparticles appeared as blue spots inside the cells, 
while the nucleus appeared red. The cells that exhibit red 
nucleus and blue intracellular particles were considered 
PB positive; the percentage of labeled cells was calculated 
within eight random fields of view per slide. The results were 
analyzed with univariate analysis of variance corrected for 
multiple comparisons (Bonferroni). P,0.05 was considered 
as statistically significant.
Isolation and characterization of labeled 
exosomes
ASCs (106 cells) were incubated with 200 µg Fe/mL of USPIO 
for 24 hours, washed, and deprived of FBS for 48 hours to avoid 
any contamination of vesicles from serum. After deprivation, 
ASC supernatants were collected, and exosomes were isolated 
using PureExo® Exosome isolation kit (101Bio, Palo Alto, 
CA, USA). The concentration of exosomes was measured in 
terms of their protein content determined by bicinchoninic 
protein assay method using the manufacturer’s protocol (Pierce 
BCA Protein Assay Kit; Thermo Fisher Scientific). Exosomes 
loaded with USPIO (exosomes-USPIO) were characterized by 
electron microscopy (as described in “Transmission electron 
microscopy” section) and Western blot analysis. Western blot 
hybridization was performed using standard protocols: after 
denaturation, 12 µg of proteins were separated on 4%–12% 
polyacrylamide gels, transferred on to a nitrocellulose mem-
brane, and incubated with antibodies anti-HSP70 and anti-
Alix (HSP70 [K-20]: sc-1060 and Alix [Q-19]: sc-49268) (all 
antibodies were purchased from Santa Cruz Biotechnology 
Inc., Dallas, TX, USA). ASC lysate was used as a positive 
control, and supernatant lacking ASCs and exosomes was 
used as a negative control. After incubation with appropriate 
horseradish peroxidase-coupled secondary antibodies (Santa 
Cruz Biotechnology Inc.), the blot was incubated with a chemi-
luminescent horseradish peroxidase substrate and detected with 
G:BOX F3 GeneSys (Syngene, Cambridge, UK).
Transmission electron microscopy
For ultrastructural morphology of cells and exosomes, cell 
pellets were fixed in 2% glutaraldehyde in Sorensen buffer 
(pH 7.4) for 2 hours, while exosomes included in an agarose 
gel were fixed with 2.5% glutaraldehyde plus 2% para-
formaldehyde in 0.1 M phosphate buffer. All samples were 
postfixed in 1% osmium tetroxide (OsO
4
) for 2 hours and 
cut. The sections were then dehydrated in graded concentra-
tions of acetone and embedded in Epon–Araldite mixture 
(Electron Microscopy Sciences, Hatfield, PA, USA). The 
semithin sections (1 µm in thickness) were examined by 
light microscopy (Olympus BX51; Olympus Corporation, 
Tokyo, Japan) and stained with toluidine blue. The ultrathin 
sections were cut at a 70 nm thickness and placed on Cu/Rh 
grids with Ultracut E (Reichert, Wien, Austria). Transmis-
sion electron microscopy (TEM) images were acquired with 
a Philips Morgagni TEM operating at 80 kV and equipped 
with a Megaview II camera for digital image acquisition.
Iron quantification in ASCs and exosomes
Quantification of intracellular iron nanoparticles in ASCs was 
performed as previously described by Rad et al.26 The cells 
were washed three times with PBS, trypsinized, counted, and 
collected in tubes (2×105 cells each). Cells were centrifuged 
at 3,000 rpm for 5 minutes and incubated with 0.5 mL of HCl 
(5 M) at room temperature for 1 hour. ASCs were then cen-
trifuged at 3,000 rpm for 5 minutes, and the supernatant was 
collected in 1.5 mL microcuvettes. Potassium ferrocyanide 
solution (5%) was added to each microcuvette and incubated 
at room temperature for 30 minutes in dark conditions. The 
absorbance was measured at 700 nm using the ultraviolet–vis-
ible spectrophotometer (Cary 60 UV/Vis Spectrophotometer; 
Agilent Technologies). The same protocol was performed for 
unlabeled cells, used as control. In order to determine the iron 
concentration per cell, the absorbance of each sample was 
divided by the number of cells per milliliter. Iron concentra-
tion was determined by normalizing the obtained absorbance 
with a previously prepared calibration curve. The calibration 
curve was obtained by preparing samples with different iron 
concentrations (0–12 µg Fe/mL); HCl (5 M) was added to 
each sample and incubated at room temperature for 1 hour. 
After incubation time, potassium ferrocyanide (5%) was 
added, and the tubes were kept for 30 minutes in dark condi-
tions. The absorbance was measured at 700 nm, and the iron 
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calibration curve was derived. The same protocol used for 
the calibration curve was performed for the quantification of 
iron content in exosomes after their isolation.
In vitro and in vivo MrI
MR images were acquired using a Bruker Tomograph (Bruker 
Optik GmbH, Ettlingen, Germany) equipped with a 4.7 T, 
33 cm bore horizontal magnet (Oxford Ltd, Oxford, UK).
For in vitro T
2
 relaxation time evaluation, ASCs were 
labeled as previously described and then homogeneously 
distributed in a gel matrix (Agarose low electroendos-
mosis; PanReac AppliChem; at 2% w/w). T
2
 maps of 
ASC-USPIO phantoms were obtained with a multislice 
multiecho sequence with repetition time (TR) =5,000 ms, 
echo time (TE
eff
) =11 ms, N echoes =16, field of view 
(FOV) =6.5×6.5 cm2, matrix size (MTX) =128/128, slice 
thickness =2 mm, and N slice =3. Relaxivity (1/s) of ASC-
USPIO nanoparticles (R2) were analyzed by using Student’s 
t-test cor rected for multiple comparisons (Bonferroni). 
P,0.05 was considered as statistically significant.
In order to assess the in vitro detectability of USPIO-
labeled ASCs and exosomes immobilized in a gel matrix, 
T
2
*-weighted images were acquired using a fast low-angle 
shot sequence with TR =625 ms, TE
eff
 =15 ms, N echoes =1, 
FOV =6.0×6.0 cm2, MTX =700/512, slice thickness =0.5 mm, 
and N slice =24. Unlabeled cells or unlabeled exosomes in 
an agarose gel were used as the respective control.
For in vivo MRI, C57BL/6 male mice (Harlan Laborato-
ries, Indianapolis, IN, USA) were used. Mice were maintained 
under standard environmental conditions (temperature, humid-
ity, 12 hours/12 hours light/dark cycle, with water and food 
ad libitum) and veterinarian assistance. Animal handling was 
performed following a protocol approved by the Animal Care 
and Use Committee of the University of Verona (CIRSAL) 
and by the Italian Ministry of Health, in strict adherence to 
the European Communities Council (86/609/EEC) directives, 
minimizing the number of animals used and avoiding their 
suffering. Animals were anesthetized by 1% isofluorane inha-
lation in a mixture of oxygen and nitrogen and were placed in 
a prone position over a heated bed and inserted into a 3.5-cm 
internal diameter birdcage radiofrequency coil.
In order to assess MRI detectability of labeled cells, 
2.5×103 and 5×103 ASC-USPIO, suspended in 100 µL of 
sterile PBS, were administered to two mice by intramuscu-
lar injection in the hind limbs. At the same time, in order 
to detect exosomes-USPIO, 5 µg and 25 µg of labeled exo-
somes (containing 0.032 µg and 0.16 µg Fe, respectively, 
and suspended in 100 µL of sterile PBS) were injected 
intramuscularly in two additional mice. In order to confirm 
the power of MRI in detecting low amounts of iron, free 
USPIO, containing the equivalent iron content of labeled 
exosomes, was injected intramuscularly in two other mice. 
To perform in vivo MRI, T
2
*-weighted images were acquired 
using a fast low-angle shot sequence with TR =625 ms, 
TE
eff
 =5 ms, FOV =7.0×3.50 cm2, MTX =512/256, slice 
thickness =0.5 mm, and N slice =24.
histological analysis of exosomes-UsPIO
After in vivo injection, the presence of exosomes in the muscle 
tissues was confirmed by histological analysis. Mice were sac-
rificed, and the gastrocnemius was dissected out, fixed in 10% 
formalin, and embedded in paraffin. All samples were cut in 
5 µm thick sections with a microtome. In order to evaluate 
the nanoparticles incorporation, PB staining was performed: 
sections were incubated with PB solution (5% hydrochloric 
acid and 5% potassium ferrocyanide) for 40 minutes and 
counterstained with nuclear fast red for 10 minutes. Sections 
were examined under a light microscope (Olympus BXS1) 
equipped with a charge-coupled device camera.
Results
cell growth and viability
In order to verify the possible cytotoxicity of USPIO, TB 
exclusion assay was performed. After ASC labeling with 
increasing amount of nanoparticles, no statistical differences 
were found, indicating that different concentrations of USPIO 
do not interfere with the viability of the cells (Table 1).
Efficiency and iron quantification of 
asc labeling
In order to verify whether ASCs were labeled with USPIO 
and to detect iron nanoparticles inside the cells, PB staining 
Table 1 Viability of ascs (assessed by Trypan blue viability test) incubated for 24 hours and 72 hours with increasing concentrations 
of UsPIO
12.5 µg Fe/mL 25 µg Fe/mL 50 µg Fe/mL 100 µg Fe/mL 200 µg Fe/mL Nonlabeled
24 hours 100.0±0 90.7±6.3 89.8±5.2 93.5±4.3 97.0±1.5 100.0±0
72 hours 96.2±2.1 98.0±1.1 97.0±2.1 100.0±0 92.9±2.3 98.7±1.1
Note: Data are shown as mean percentage ± seM.
Abbreviations: ascs, adipose stem cells; seM, standard error of the mean; UsPIO, ultrasmall superparamagnetic iron oxide nanoparticles.
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was performed. This staining is used to identify the presence 
of nanoparticles: the reduction of ferric to ferrous iron results 
in the formation of blue precipitates. PB and nuclear fast red 
staining of labeled cells clearly showed red nucleus and blue 
cytoplasmic inclusions with typical perinuclear localization 
indicating the presence of USPIO (Figure 1A). Labeled 
cells were detected after incubation using the lowest dose 
of nanoparticles (12.5 µg Fe/mL) and the shortest incuba-
tion time (24 hours). The increase in iron concentration 
(100 µg Fe/mL and 200 µg Fe/mL) and incubation time 
(72 hours) resulted in a stronger PB cell staining, due to 
increasing amounts of USPIO internalization (Figure 1A). 
When ASCs were incubated 24 hours with increasing iron 
concentrations (12.5 µg Fe/mL, 25 µg Fe/mL, 50 µg Fe/mL, 
100 µg Fe/mL, and 200 µg Fe/mL), a consistent increase in 
the percentage of labeled cells was detected (35.4%, 49.5%, 
77.6%, 85.8%, and 87.2%, respectively, at the concentra-
tions mentioned earlier), showing a dose-dependent nano-
particle internalization (Figure 1B). After 72 hours of ASC 
incubation with the nanoparticle concentrations mentioned 
earlier, we obtained 80.2%, 88.2%, 95.8%, 97%, and 100% 
of labeled cells, respectively (Figure 1B). Labeling of ASCs 
was found to be dose dependent and time dependent: the 
percentage of nanoparticles internalization increased both 
with increasing USPIO concentrations and with increasing 
incubation times.
In addition, in order to confirm the intracellular uptake 
of nanoparticles and visualize their intracellular localization, 
TEM images of ASC-USPIO were acquired (Figure 1C 
and D). TEM analysis showed that iron nanoparticles were 
accumulated inside the cells and localized exclusively 
in the cytoplasm. Moreover, TEM analysis revealed that 
USPIO were contained inside the labeled cells in endo-
cytic vesicles (Figure 1D). TEM image of unlabeled cells 
as negative control was reported (Figure 1E). Iron content 
measures in ASC-USPIO showed intracellular concen-
trations of 6.20±0.0036 pg/cell, 7.58±0.0050 pg/cell, 
and 9.39±0.007 pg/cell (data expressed as mean ± SD) 
at concentrations of 50 µg Fe/mL, 100 µg Fe/mL, and 
200 µg Fe/mL, respectively, after 24 hours of incubation. 
???
? ?
? ? ?
??
??
????
????
????
???
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????
???????? ???????? ????????
?? ?????? ??? ??? ???
?
???????? ????????
Figure 1 Intracellular uptake of UsPIO.
Notes: (A) Prussian blue staining of ascs to detect the presence of iron nanoparticles after UsPIO incubation. The image clearly shows a red nucleus and a blue cytoplasmic 
inclusion with typical perinuclear localization that indicate the presence of USPIO within the cells (magnification ×20, scale bar 50 µm). (B) Percentage of labeled cells after 
24 hours and 72 hours of incubation with UsPIO. Data expressed as mean ± sD. (C and D) TeM images of asc incubated for 72 h with 200 µg Fe/ml of UsPIO. In C, the 
scale bar is 5,000 nm; in D note the endocytic invagination containing nanoparticles and the internalized nanoparticles inside the endosome (scale bar 2,000 nm). In C and D 
arrows indicate the presence of nanoparticles inside the cell. (E) TeM image of unlabeled ascs as negative control (scale bar 5,000 nm).
Abbreviations: asc, adipose stem cell; TeM, transmission electron microscopy; UsPIO, ultrasmall superparamagnetic iron oxide nanoparticles.
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At 72 hours of incubation, intracellular iron content in 
ASC-USPIO was 10.52±0.66 pg/cell, 11.22±0.013 pg/cell, 
and 14.77±0.021 pg/cell (data expressed as mean ± SD) 
at concentrations of 50 µg Fe/mL, 100 µg Fe/mL, and 
200 µg Fe/mL, respectively. These data are consistent with 
the total iron content reported in the literature for iron oxide-
labeled cells.26 Moreover, the results obtained from the quan-
tification of intracellular iron were in line with PB staining: a 
dose- and time-dependent uptake of USPIO was detected.
MrI of asc-UsPIO
T
2
 parametric maps were acquired in gel phantoms con-
taining ASC-USPIO in order to determine the optimal 
experimental parameters for MRI detection, in terms of 
both incubation time and iron concentration. The analysis 
of R2 values (1/s) revealed an incubation time and USPIO 
concentration-dependent behavior (Figure 2A). After 
24 hours of incubation, a significant difference (P,0.05) 
in R2 values was detected between 100 µg Fe/mL and 
200 µg Fe/mL. After 72 hours of incubation, ASC-USPIO 
phantoms exhibited significant (P,0.05) differences in 
R2 values between phantoms containing cells labeled with 
50 µg Fe/mL, 100 µg Fe/mL, or 200 µg Fe/mL. Moreover, 
no significant difference in R2 values was detected between 
24 hours and 72 hours of incubation at 200 µg Fe/mL. MRI 
signal of unlabeled cells was comparable to water signal.
?? ? ??
?
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??
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?
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Figure 2 MrI of asc-UsPIO.
Notes: (A) r2 values (1/s) of ascs unlabeled and labeled with increasing UsPIO concentrations (12.5 µg Fe/ml, 25 µg Fe/ml, 50 µg Fe/ml, 100 µg Fe/ml, and 200 µg Fe/ml) 
after 24 hours and 72 hours of incubation. Data expressed as mean ± sD. *P,0.05. r2, relaxivity (1/s) of asc-UsPIO nanoparticles. (B) representative Mr images of gel 
phantom containing labeled ascs acquired for the evaluation of the detection limit. Different amounts (from 102 to 105 cells) of ASC-USPIO were used. MRI can efficiently 
detect up to 102 cells in vitro. In vivo Mr images of acquired preintramuscular (C) and postintramuscular (D) injections of 5×103 (dotted arrow) and 2.5×103 (arrow) 
asc-UsPIO. after intramuscular injection (D), we detected up to 2.5×103 asc-UsPIO.
Abbreviations: asc, adipose stem cell; Mr, magnetic resonance; MrI, magnetic resonance imaging; UsPIO, ultrasmall superparamagnetic iron oxide nanoparticles.
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Based on the results described earlier and the lack of 
significant effects on cell viability, a combination of 200 µg 
Fe/mL of USPIO and 72 hours of incubation time was chosen 
for further experiments.
In order to test the detectability and evaluate the detec-
tion limit of ASC-USPIO with MRI, decreasing numbers of 
labeled ASCs (105, 104, 103, and 102 cells) were immobilized 
in different gel tubes (agarose at 2% w/w, 1.5 mL). Tubes 
containing unlabeled cells and free agarose gel were used as 
control. T
2
*-weighted images of the tubes containing ASC-
USPIO revealed the presence of hypointense spots, attrib-
utable to the presence of iron nanoparticles. These results 
showed that, by using the labeling protocol described earlier, 
MRI can efficiently detect a small amount of ASC-USPIO, 
down to 102 cells in vitro (Figure 2B). Unlabeled cells were 
not detectable in MR images.
Having established a protocol allowing the efficient 
detection of ASCs in vitro, we carried out further studies 
aimed at understanding whether USPIO-labeled cells could 
be localized by MRI in muscle tissues. For in vivo experi-
ments, two different amounts of USPIO-labeled or unlabeled 
ASCs (2.5×103 and 5×103) were intramuscularly injected in 
the hind limbs of mice. By using this method, we were able 
to detect 2.5×103 ASC-USPIO (Figure 2C and D).
Isolation and characterization of 
exosomes-UsPIO
Exosomes were isolated from labeled ASC supernatants 
obtained after USPIO incubation of 24 hours. In particular, 
whereas R2 values of ASC-USPIO after 24 hours and 72 hours 
of incubation were not statistically significantly different 
and, above all, to avoid a long incubation time (72 hours 
of nanoparticles incubation +48 hours of FBS deprivation) 
that could induce cell suffering, we decided to perform a 
USPIO incubation of 24 hours. Exosomes were quantified 
using protein concentration: for each isolation, the yield was 
100–150 µg/mL of exosomal proteins. Western blot analysis 
of isolated vesicles showed a signal at 70 kDa and 95 kDa, 
after incubation with HSP70 and Alix antibodies, respectively 
(Figure 3A), confirming that isolated vesicles were exosomes. 
We then performed ultrastructural morphology analysis by 
TEM, in order to prove that the exosomal fraction still con-
tained USPIO. TEM images clearly showed dark spots inside 
the vesicles, confirming the presence of iron nanoparticles 
(labeled exosomes) (Figure 3C). Finally, using the spectro-
photometric method, exosomes-USPIO were found to contain 
0.643 µg of iron per 100 µg of exosomal proteins.
MrI of exosomes-UsPIO
After isolation and characterization, 3 µg of exosomes-
USPIO were immobilized in a gel matrix (agarose at 2% 
w/w). T
2
*-weighted images were used to assess the presence 
of exosomes-USPIO with MRI. Exosomes were detectable 
as a hypointense spot in the gel matrix (Figure 3B). Unla-
beled exosomes immobilized in an agarose gel were used as 
control. In order to confirm that MR images really reported 
exosomes-USPIO, we performed TEM on the portion of 
gel visualized as a hypointense spot in MRI. TEM images 
clearly confirmed the presence of labeled exosomes within 
the agarose gel (Figure 3C).
Having efficiently visualized exosomes-USPIO in vitro, 
we focused on the in vivo MRI detection of labeled exosomes 
??? ? ?
???????????
??????????
??????
??? ??
Figure 3 characterization and visualization of exosomes-UsPIO.
Notes: (A) Western blot analysis of the expression of hsP70 (70 kDa) and alix (95 kDa) in exosomes. supernatant lacking the asc and exosomes was used as Nc. (B) On 
the left, MR images of exosomes-USPIO (top) and unlabeled exosomes (bottom) immobilized in gel are shown. The square images on the right show a higher magnification 
of the areas of interest in each Mr image. (C) TeM image of exosomes (arrows) previously visualized by MrI in gel (B) and finally processed for electron microscopy; they 
are still labeled with nanoparticles (scale bar 100 nm).
Abbreviations: asc, adipose stem cell; cl, asc cell lysate; eXO, exosomes; Mr, magnetic resonance; MrI, magnetic resonance imaging; Nc, negative control; 
TeM, transmission electron microscopy; UsPIO, ultrasmall superparamagnetic iron oxide nanoparticles.
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in mice after intramuscular injection of labeled exosomes. 
Coronal T
2
*-weighted images of hind limbs pre- and postin-
tramuscular injections of 5 µg of exosomes-USPIO are 
shown in Figure 4A and B. In vivo MR images revealed that 
exosomes-USPIO were clearly detectable in the muscular 
tissue. Histological examination of gastrocnemius confirmed 
the presence of iron: PB staining showed several blue spots 
inside the muscle fibers in a spatially limited region close 
to the injection site (Figure 4C and D). In mice receiving 
an intramuscular injection of plain USPIO containing the 
same amount of iron of labeled exosomes, the MR images 
clearly showed localized loss of signal comparable with that 
detected in images of mice injected with exosomes-USPIO, 
confirming the high sensitivity of MRI (Figure 4E and F).
Discussion
The safe and easy availability of ASCs and their ability to 
migrate to damaged tissues and contribute to reparative pro-
cesses render these cells of great interest in neurodegenerative 
diseases. In the last decade, several studies have demon-
strated that the therapeutic potential of ASCs could be due 
to their paracrine activity rather than to their integration 
and survival in host tissues.4–6 In particular, the paracrine 
mechanism seems to be mediated through exosomes release,3 
Figure 4 In vivo MrI of exosomes-UsPIO.
Notes: In vivo Mr images acquired preintramuscular (A) and postintramuscular (B) injections of exosomes-UsPIO (arrow). Prussian blue histological examination of 
extracted muscle tissue: blue spots inside the muscle confirmed the presence of iron nanoparticles (C) (magnification ×20, scale bar 50 µm). D shows a higher magnification 
(×40, scale bar 50 µm) of the boxed area shown in C. In vivo Mr images acquired preintramuscular (E) and postintramuscular (F) injections of plain UsPIO (arrow) containing 
the same amount of iron of labeled exosomes; the signal is comparable with that detected in exosomes-UsPIO (B).
Abbreviations: Mr, magnetic resonance; MrI, magnetic resonance imaging; UsPIO, ultrasmall superparamagnetic iron oxide nanoparticles.
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making exosomes a potential alternative to cell therapy in 
neurodegenerative diseases.
The ability to visualize and track exosomes with a nonin-
vasive tool, such as MRI,27 would be key for the understand-
ing of the biological mechanisms (eg, homing, functional 
capabilities, and site of action), which are at the basis of their 
potential. To this purpose, we have set up a new method to 
label exosomes with iron oxide nanoparticles. USPIO are 
an optimal candidate for exosomes labeling: they are stable, 
biocompatible, ranging in size from 5 nm to 7 nm, and 
hence sufficiently small to be incorporated in exosomes.27 
Recently, USPIO have been used to label exosomes by the 
electroporation technique;23 to date, despite variable results,25 
electroporation is one of the most frequently used methods to 
load cells and exosomes with cargo.23,28 However, electropo-
ration may affect membrane integrity since the membrane is 
exposed to a strong electric field to cause spontaneous pore 
formation. It is well established that exosomes carry out their 
biological function by transferring their content to the target 
cell. This mechanism requires first, interaction between exo-
somes and cell membranes and second, membranes’ fusion 
and exosomes’ internalization.10,11 For this reason, it is fun-
damental to preserve the integrity of the exosome membrane. 
In our study, we propose a new protocol to label exosomes 
with USPIO starting by labeling cells, which avoids direct 
manipulation of exosome membranes.
First of all, we optimized the parameters to label ASCs 
in terms of cell viability, labeling efficiency, iron content, 
and MR image contrast. TEM images showed that labeled 
ASCs incorporate USPIO by endocytic mechanisms, as 
already reported.29 It has been demonstrated that nanopar-
ticles internalized by endocytosis often accumulate inside 
multivesicular bodies,30 which, in turn, may fuse with the 
plasma membrane thus releasing their cargo (exosomes).31 
It is likely that USPIO undergo the same secretion process 
of the endosomal system.
MRI experiments were designed to find the highest 
detectable nanoparticle concentrations compatible with cell 
viability and to establish the lowest detectable USPIO-labeled 
cell numbers. Our results showed that MRI is able to visu-
alize 102-labeled cells, an amount that is several orders of 
magnitude lower than what is normally used in in vivo animal 
disease models.4–6 The next step was to evaluate whether 
exosomes isolated from ASC-USPIO retain nanoparticles 
and if they could be visualized by MRI. In vitro MR images 
of exosomes-USPIO showed a localized hypointense region, 
attributable to the presence of iron nanoparticles, as confirmed 
by TEM. Moreover, we were able to detect exosomes-USPIO 
in vivo with MRI after intramuscular injection. The magnetic 
susceptibility artifact had the typical shape of the magnetic 
dipole field lines. A similar susceptibility artifact appeared 
when an equivalent amount of USPIO (in terms of iron con-
tent) was injected. The presence of USPIO was confirmed 
by the histological analysis of muscular tissues.
Conclusion
The production of labeled exosomes through labeled cells 
does not alter the vesicles membrane and therefore allows 
preservation of their integrity. This innovative method 
opens up the possibility of tracking exosomes in vivo with 
a powerful and noninvasive technique, such as MRI, and 
could represent a significant step forward to the unveiling 
of exosome homing and, more broadly, their role in normal 
and pathological conditions.
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